Medical Device Network on MSN
Edwards boosts FY25 outlook after Q3 surpasses expectations
The company achieved sales growth of 14.7% to around $1.55bn in Q3. Edwards now expects FY25 sales growth to come in at the ...
A new study published in the Journal of Clinical Anesthesia shows that family members and caregivers can play a critical role ...
Medical Device Network on MSN
FDA clears ViTAA Medical’s AI aortic surgery planning tool
ViTAA Medical’s aortic surgery planning tool has gained clearance from the US Food and Drug Administration (FDA), ...
Inder Paul Singh, a glaucoma anterior segment surgeon from southeastern Wisconsin, presented his clinical experience and a ...
Brittany Cartwright revealed that she is “getting better everyday” after going under the knife for “mommy makeover” surgery nearly one month ago. As part of her procedure, Cartwright also got new ...
A P rospective rA ndomized tR ial A ssessing the safety and effectiveness of the D urAVR® bI omimetic valve designed for physioloG ic ...
The Centers for Medicare and Medicaid Services in August published the latest, nationwide hospital quality ratings. The good news: New York state moved up in the rankings. The bad news: it only inched ...
Denver, CO October 21, 2025 –(PR.com)– Part of a Leading Trend: Parkview Care Center Among Colorado’s Top-Quality Honorees 2025 Bronze–Commitment to Quality Award from the American Health Care ...
If you know what a TAVR procedure is; a shiny gold star for you. And if you know why, at Overlake Medical Center, they call the second day of the work week “TAVR Tuesdays,” you get two gold stars. And ...
WASHINGTON (AP) — The government shutdown has reopened debate on what has been a central issue for both major political parties in the last 15 years: the future of health coverage under the Affordable ...
One of the most important issues facing our country right now is the rise in violent crime. The tragic shooting in Montgomery earlier this month is a heartbreaking reminder of this issue’s urgency.
LDL levels were reduced substantially among heart transplant recipients assigned alirocumab. NEW ORLEANS — In the CAVIAR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results